MUX McEwen
McEwen earnings company data as of 5:02 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.07 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by MUX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $18K bought by 1 insider
- $59K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Richard W. Brissenden DirectorSale$59K 3,275 shares at $18.13 15% of stakeTraded Jun 29 Filed Jul 1
-
Stephen Douglas Kaszas DirectorBuy$18K 1,000 shares at $18.36 +161% to stakeTraded Jun 5 Filed Jun 9
-
Stephan Michael Spears VP Corporate DevelopmentSale$181K 12,600 shares at $14.35 77% of stakeTraded Sep 19, 2025 Filed Nov 19, 2025
Also filed in the last 12 months, not counted as buying or selling: 34 option exercises and 1 stock grant.
SEC filings
Recent issuer filings from EDGAR, 23 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 10-K/A | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K/A | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 10-K/A | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| DEF 14A | FORM- DEF 14A | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.